Equity Profile

CC

The Chemours Company

MaterialsDiversified Chemicals$2.3B

Aug4Tue

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

The Chemours Company (CC) is a global leader in the diversified chemicals sector, specializing in titanium technologies, fluoroproducts, and chemical solutions. With a market cap of $2 billion, Chemours plays a crucial role in various industries, including automotive, electronics, and construction, making it an important player in the materials market.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well Chemours managed costs and revenue this quarter.

$0.42

Revenue

Total revenue reflects the company's sales performance and market demand for its products, which is critical for growth.

$1.7B

Wall Street expectations, options signals, track record, and call prep available with Pro.

CC Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+329.95%

Avg Stock Reaction

+1.98%

Last Quarter Recap

In Q1-2026, Chemours reported an EPS of $0.05, significantly beating expectations, which led to a positive stock reaction. However, revenue figures were not disclosed, leaving some uncertainty about overall performance.

Management Promises & Guidance

Focus on improving operational efficiencies.
Commitment to sustainable product development.
Plans to expand market share in key sectors.

Expectations

Wall Street Expectations

Analysts expect Chemours to report a modest EPS of $0.42 and revenue of $1.7 billion, indicating cautious optimism in the market. The stock's recent performance suggests investors are looking for signs of continued recovery.

Bull Case

If Chemours exceeds EPS estimates and shows strong revenue growth, it could signal a robust recovery and increased demand for its products, boosting investor confidence.

Bear Case

Conversely, if the company falls short of EPS expectations or revenue growth is stagnant, it may raise concerns about its competitive position and market demand, leading to a negative stock reaction.

Key Metrics to Watch

EPS

$0.42

Earnings per share is a key indicator of profitability and will show how well Chemours managed costs and revenue this quarter.

Revenue

$1.7B

Total revenue reflects the company's sales performance and market demand for its products, which is critical for growth.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Chemours achieve an EPS of $0.42 or better?

This EPS figure is crucial for assessing the company's profitability and could influence investor sentiment significantly.

What will the revenue figure be, and how does it compare to the $1.7 billion consensus?

Revenue performance will indicate market demand and the effectiveness of Chemours' strategies, impacting future growth expectations.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Chemours' ability to leverage its recent operational improvements and market demand, leading to better-than-expected results.

Supporting Evidence

Chemours has a strong track record of beating EPS estimates, with a 75% beat rate in recent quarters.

The options market is pricing for significant volatility, suggesting that traders expect a larger move than historical averages.

Recent operational efficiencies may not be fully reflected in analyst expectations.

Key Risk

If Chemours reports an EPS significantly above $0.42, it could shift market perceptions and validate a stronger growth narrative.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's results will hinge on Chemours' ability to meet or exceed earnings expectations and demonstrate solid revenue growth.

Bull Confirmed If

An EPS of $0.50 or higher would confirm strong operational performance and market demand.

Bear Confirmed If

An EPS below $0.30 would raise concerns about profitability and market competitiveness.

Pre-Earnings Positioning

Options Market

Implied Move

±17.46%

Historical Avg

±4.38%

Pricing rich

The options market is pricing in a significant move following the earnings report, indicating heightened expectations for volatility.

Options price a 17.46% move while the stock has averaged only a 4.38% move over the last 8 quarters, suggesting a rich setup.

Detail

ATM IV

0.7%

30d HV

76.5%

Calls (40K)P/C Ratio: 1.86Puts (44K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Chemours beats expectations, history suggests a potential stock increase of around +3.23%, confirming a positive outlook.

In-Line / Cautious

An in-line report may lead to muted reactions, as investors weigh management's commentary against expectations.

Miss

A miss on earnings could lead to a decline of about -1.78%, reflecting disappointment in performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on operational efficiency improvements.
2Details on revenue growth in key markets.
3Insights into demand trends for Chemours' products.
4Management's outlook on future market conditions.
5Comments on sustainability initiatives and their impact on growth.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well Chemours managed costs and revenue this quarter.

$0.42

Revenue

Total revenue reflects the company's sales performance and market demand for its products, which is critical for growth.

$1.7B

Wall Street expectations, options signals, track record, and call prep available with Pro.

CC Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+329.95%

Avg Stock Reaction

+1.98%

Last Quarter Recap

Management Promises & Guidance

Focus on improving operational efficiencies.
Commitment to sustainable product development.
Plans to expand market share in key sectors.

Expectations

Wall Street Expectations

Bull Case

If Chemours exceeds EPS estimates and shows strong revenue growth, it could signal a robust recovery and increased demand for its products, boosting investor confidence.

Bear Case

Conversely, if the company falls short of EPS expectations or revenue growth is stagnant, it may raise concerns about its competitive position and market demand, leading to a negative stock reaction.

Key Metrics to Watch

EPS

$0.42

Earnings per share is a key indicator of profitability and will show how well Chemours managed costs and revenue this quarter.

Revenue

$1.7B

Total revenue reflects the company's sales performance and market demand for its products, which is critical for growth.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Chemours achieve an EPS of $0.42 or better?

This EPS figure is crucial for assessing the company's profitability and could influence investor sentiment significantly.

What will the revenue figure be, and how does it compare to the $1.7 billion consensus?

Revenue performance will indicate market demand and the effectiveness of Chemours' strategies, impacting future growth expectations.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Chemours' ability to leverage its recent operational improvements and market demand, leading to better-than-expected results.

Supporting Evidence

Chemours has a strong track record of beating EPS estimates, with a 75% beat rate in recent quarters.

The options market is pricing for significant volatility, suggesting that traders expect a larger move than historical averages.

Recent operational efficiencies may not be fully reflected in analyst expectations.

Key Risk

If Chemours reports an EPS significantly above $0.42, it could shift market perceptions and validate a stronger growth narrative.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's results will hinge on Chemours' ability to meet or exceed earnings expectations and demonstrate solid revenue growth.

Bull Confirmed If

An EPS of $0.50 or higher would confirm strong operational performance and market demand.

Bear Confirmed If

An EPS below $0.30 would raise concerns about profitability and market competitiveness.

Pre-Earnings Positioning

Options Market

Implied Move

±17.46%

Historical Avg

±4.38%

Pricing rich

The options market is pricing in a significant move following the earnings report, indicating heightened expectations for volatility.

Options price a 17.46% move while the stock has averaged only a 4.38% move over the last 8 quarters, suggesting a rich setup.

Detail

ATM IV

0.7%

30d HV

76.5%

Calls (40K)P/C Ratio: 1.86Puts (44K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Chemours beats expectations, history suggests a potential stock increase of around +3.23%, confirming a positive outlook.

In-Line / Cautious

An in-line report may lead to muted reactions, as investors weigh management's commentary against expectations.

Miss

A miss on earnings could lead to a decline of about -1.78%, reflecting disappointment in performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on operational efficiency improvements.
2Details on revenue growth in key markets.
3Insights into demand trends for Chemours' products.
4Management's outlook on future market conditions.
5Comments on sustainability initiatives and their impact on growth.